एपीए उद्धरण

Rasul, S., Hacker, M., Kretschmer-Chott, E., Leisser, A., Grubmüller, B., Kramer, G., . . . Haug, A. R. (2019). Clinical outcome of standardized (177)Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks. Eur J Nucl Med Mol Imaging.

शिकागो स्टाइल उद्धरण

Rasul, Sazan, et al. "Clinical Outcome of Standardized (177)Lu-PSMA-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks." Eur J Nucl Med Mol Imaging 2019.

एमएलए उद्धरण

Rasul, Sazan, et al. "Clinical Outcome of Standardized (177)Lu-PSMA-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks." Eur J Nucl Med Mol Imaging 2019.